Clinical Trials Browser

Phase 1 × Carcinoma, Hepatocellular × Lenalidomide × Clear all

NCT01348503 2015-08-31

Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma

Phase 1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular